Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis

Abstract 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) can detect vascular inflammation in large-vessel vasculitis (LVV). Clinical factors that influence distribution of FDG into the arterial wall and other tissues have not been characterized in LVV. Understanding these factors wil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joel S. Rosenblum, Kaitlin A. Quinn, Casey A. Rimland, Nehal N. Mehta, Mark A. Ahlman, Peter C. Grayson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4ab510f0915f4897afe3ab287e64d818
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4ab510f0915f4897afe3ab287e64d818
record_format dspace
spelling oai:doaj.org-article:4ab510f0915f4897afe3ab287e64d8182021-12-02T15:07:55ZClinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis10.1038/s41598-019-51800-x2045-2322https://doaj.org/article/4ab510f0915f4897afe3ab287e64d8182019-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-51800-xhttps://doaj.org/toc/2045-2322Abstract 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) can detect vascular inflammation in large-vessel vasculitis (LVV). Clinical factors that influence distribution of FDG into the arterial wall and other tissues have not been characterized in LVV. Understanding these factors will inform analytic strategies to quantify vascular PET activity. Patients with LVV (n = 69) underwent 141 paired FDG-PET imaging studies at one and two hours per a delayed image acquisition protocol. Arterial uptake was quantified as standardized uptake values (SUVMax). SUVMean values were obtained for background tissues (blood pool, liver, spleen). Target-to-background ratios (TBRs) were calculated for each background tissue. Mixed model multivariable linear regression was used to identify time-dependent associations between FDG uptake and selected clinical features. Clinical factors associated with FDG distribution differed in a tissue- and time-dependent manner. Age, body mass index, and C-reactive protein were significantly associated with arterial FDG uptake at both time points. Clearance factors (e.g. glomerular filtration rate) were significantly associated with FDG uptake in background tissues at one hour but were weakly or not associated at two hours. TBRs using liver or blood pool at two hours were most strongly associated with vasculitis-related factors. These findings inform standardization of FDG-PET protocols and analytic approaches in LVV.Joel S. RosenblumKaitlin A. QuinnCasey A. RimlandNehal N. MehtaMark A. AhlmanPeter C. GraysonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Joel S. Rosenblum
Kaitlin A. Quinn
Casey A. Rimland
Nehal N. Mehta
Mark A. Ahlman
Peter C. Grayson
Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis
description Abstract 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) can detect vascular inflammation in large-vessel vasculitis (LVV). Clinical factors that influence distribution of FDG into the arterial wall and other tissues have not been characterized in LVV. Understanding these factors will inform analytic strategies to quantify vascular PET activity. Patients with LVV (n = 69) underwent 141 paired FDG-PET imaging studies at one and two hours per a delayed image acquisition protocol. Arterial uptake was quantified as standardized uptake values (SUVMax). SUVMean values were obtained for background tissues (blood pool, liver, spleen). Target-to-background ratios (TBRs) were calculated for each background tissue. Mixed model multivariable linear regression was used to identify time-dependent associations between FDG uptake and selected clinical features. Clinical factors associated with FDG distribution differed in a tissue- and time-dependent manner. Age, body mass index, and C-reactive protein were significantly associated with arterial FDG uptake at both time points. Clearance factors (e.g. glomerular filtration rate) were significantly associated with FDG uptake in background tissues at one hour but were weakly or not associated at two hours. TBRs using liver or blood pool at two hours were most strongly associated with vasculitis-related factors. These findings inform standardization of FDG-PET protocols and analytic approaches in LVV.
format article
author Joel S. Rosenblum
Kaitlin A. Quinn
Casey A. Rimland
Nehal N. Mehta
Mark A. Ahlman
Peter C. Grayson
author_facet Joel S. Rosenblum
Kaitlin A. Quinn
Casey A. Rimland
Nehal N. Mehta
Mark A. Ahlman
Peter C. Grayson
author_sort Joel S. Rosenblum
title Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis
title_short Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis
title_full Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis
title_fullStr Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis
title_full_unstemmed Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis
title_sort clinical factors associated with time-specific distribution of 18f-fluorodeoxyglucose in large-vessel vasculitis
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/4ab510f0915f4897afe3ab287e64d818
work_keys_str_mv AT joelsrosenblum clinicalfactorsassociatedwithtimespecificdistributionof18ffluorodeoxyglucoseinlargevesselvasculitis
AT kaitlinaquinn clinicalfactorsassociatedwithtimespecificdistributionof18ffluorodeoxyglucoseinlargevesselvasculitis
AT caseyarimland clinicalfactorsassociatedwithtimespecificdistributionof18ffluorodeoxyglucoseinlargevesselvasculitis
AT nehalnmehta clinicalfactorsassociatedwithtimespecificdistributionof18ffluorodeoxyglucoseinlargevesselvasculitis
AT markaahlman clinicalfactorsassociatedwithtimespecificdistributionof18ffluorodeoxyglucoseinlargevesselvasculitis
AT petercgrayson clinicalfactorsassociatedwithtimespecificdistributionof18ffluorodeoxyglucoseinlargevesselvasculitis
_version_ 1718388313218351104